$默沙东(MRK)$ PDUFA date is expected on September 7, 2023.美国FDA接受优先审查默克公司PREVYMIS™在高危肾移植受者中预防巨细胞病毒病的补充新药申请 网页链接{U.S. FDA Accepts for Priority Review the Supplemental New Drug Application for Merck’s PREVYMIS™ for Prophylaxis of Cytomegalovirus Disease in Kidney Transplant Recipients at High Risk | Business Wire}